Quote:

---

but he probably already has ARDS so not sure he could be helped at that point.

---

The protocol for the trial is for those who are mildly to moderately affected because that will be the easiest to achieve with no deaths because the patient is to far gone. But where leronlimab will shine is in the severe cases. Bringing people back from the brink of death is the much greater achievement.